hematopoiesis

• Myelodysplastic syndromes are bone marrow stem cell disorders resulting in disorderly and ineffective hematopoiesis (blood production) manifested by irreversible quantitative and qualitative defects in hematopoietic (blood-forming) cells. —  Free the Animal
• "Scl has been well studied and is a paradigm for hematopoiesis," she said. —  PhysOrg.com - latest science and technology news stories
• He completed his post-doctoral training in the Laboratory of Molecular Oncology at the National Cancer Institute where his research efforts focused in the areas of oncology, hematopoiesis, and gene therapy. —  News
• The myelodysplastic syndromes (MDS) comprise a group of premalignant hematologic disorders characterized by ineffective hematopoiesis, dysplasia, and transformation to acute myeloid leukemia (AML). —  Proceedings of the National Academy of Sciences current issue
• Myelodysplastic syndromes are group of diseases of blood and bone marrow (stem cells), a collection of hematological conditions characterized by hampered production of myeloid blood cells, it also involves problems related to blood production (hematopoiesis) characterized by defects in blood-forming cells (hematopoietic cells).

Used in the Same Context